A Multicenter, Eight-Week Treatment, Single-Step Titration Open-Label Study Assessing The Percentage Of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target With Atorvastatin Starting Doses Of 10 MG, 20 MG, And 40 MG.

Trial Profile

A Multicenter, Eight-Week Treatment, Single-Step Titration Open-Label Study Assessing The Percentage Of Korean Dyslipidemic Patients Achieving LDL Cholesterol Target With Atorvastatin Starting Doses Of 10 MG, 20 MG, And 40 MG.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Aug 2009

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Dyslipidaemias; Lipid metabolism disorders
  • Focus Therapeutic Use
  • Acronyms AT-GOAL
  • Sponsors Pfizer
  • Most Recent Events

    • 01 Jul 2009 Planned number of patients changed from 416 to 425 as reported by ClinicalTrials.gov.
    • 04 Jun 2008 Status changed from recruiting to in progress according to ClinicalTrials.gov.
    • 09 Apr 2008 Status changed from recruiting to in progress, reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top